首页> 外文期刊>International Journal of Pharmaceutics >Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studies.
【24h】

Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studies.

机译:平阳霉素PLGA微球的制备及相关的体内/体外研究。

获取原文
获取原文并翻译 | 示例
       

摘要

Using a multiple emulsion solvent evaporation method, pingyangmycin was entrapped in poly(lactic-co-glycolic acid) (PLGA) to prepare a long-acting pingyangmycin PLGA microsphere formulation that can be sustainably released with high entrapment efficiency. Meanwhile, the effects of stirring speed during the multiple emulsion solvent evaporation process were also taken into consideration. Investigation of the in vitro release properties showed that the microsphere formulations could sustainably release the drug over nearly 28 d, and, moreover, it could stably control pingyangmycin release over nearly 24 d when intramuscularly injected into dogs. No serious toxic effect was observed in an acute toxicity test in mice. A subcutaneous xenotransplant model of hepatoma H(22) in mice was established for pharmacodynamic studies and the results showed that the process of preparing pingyangmycin PLGA microsphere formulations was feasible and that intramuscular injection of this microsphere formulation resulted in anti-tumor activity in vivo.
机译:使用多重乳液溶剂蒸发法,将平阳霉素截留在聚乳酸-乙醇酸共聚物(PLGA)中,以制备长效平阳霉素PLGA微球制剂,该制剂可以高包封率持续释放。同时,还考虑了多重乳液溶剂蒸发过程中搅拌速度的影响。对体外释放特性的研究表明,微球制剂可以在近28 d内持续释放该药物,此外,当肌肉注射到狗中时,它可以在近24 d内稳定地控制平阳霉素的释放。在小鼠的急性毒性试验中未观察到严重的毒性作用。建立了小鼠肝癌H(22)的皮下异种移植模型以进行药效学研究,结果表明制备平阳霉素PLGA微球制剂的过程是可行的,并且该微球制剂的肌内注射导致体内抗肿瘤活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号